261 related articles for article (PubMed ID: 32488125)
1. Cell-type specific modulation of NMDA receptors triggers antidepressant actions.
Pothula S; Kato T; Liu RJ; Wu M; Gerhard D; Shinohara R; Sliby AN; Chowdhury GMI; Behar KL; Sanacora G; Banerjee P; Duman RS
Mol Psychiatry; 2021 Sep; 26(9):5097-5111. PubMed ID: 32488125
[TBL] [Abstract][Full Text] [Related]
2. GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions.
Gerhard DM; Pothula S; Liu RJ; Wu M; Li XY; Girgenti MJ; Taylor SR; Duman CH; Delpire E; Picciotto M; Wohleb ES; Duman RS
J Clin Invest; 2020 Mar; 130(3):1336-1349. PubMed ID: 31743111
[TBL] [Abstract][Full Text] [Related]
3. Positive modulation of NMDA receptors by AGN-241751 exerts rapid antidepressant-like effects via excitatory neurons.
Pothula S; Liu RJ; Wu M; Sliby AN; Picciotto MR; Banerjee P; Duman RS
Neuropsychopharmacology; 2021 Mar; 46(4):799-808. PubMed ID: 33059355
[TBL] [Abstract][Full Text] [Related]
4. NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine.
Zanos P; Brown KA; Georgiou P; Yuan P; Zarate CA; Thompson SM; Gould TD
J Neurosci; 2023 Feb; 43(6):1038-1050. PubMed ID: 36596696
[TBL] [Abstract][Full Text] [Related]
5. Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy.
Widman AJ; McMahon LL
Proc Natl Acad Sci U S A; 2018 Mar; 115(13):E3007-E3016. PubMed ID: 29531088
[TBL] [Abstract][Full Text] [Related]
6. NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism.
Kiselycznyk C; Jury NJ; Halladay LR; Nakazawa K; Mishina M; Sprengel R; Grant SG; Svenningsson P; Holmes A
Behav Brain Res; 2015; 287():89-95. PubMed ID: 25800971
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-relevant concentrations of the ketamine metabolite (2
Lumsden EW; Troppoli TA; Myers SJ; Zanos P; Aracava Y; Kehr J; Lovett J; Kim S; Wang FH; Schmidt S; Jenne CE; Yuan P; Morris PJ; Thomas CJ; Zarate CA; Moaddel R; Traynelis SF; Pereira EFR; Thompson SM; Albuquerque EX; Gould TD
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5160-5169. PubMed ID: 30796190
[TBL] [Abstract][Full Text] [Related]
8. Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-Like Effects.
Donello JE; Banerjee P; Li YX; Guo YX; Yoshitake T; Zhang XL; Miry O; Kehr J; Stanton PK; Gross AL; Burgdorf JS; Kroes RA; Moskal JR
Int J Neuropsychopharmacol; 2019 Mar; 22(3):247-259. PubMed ID: 30544218
[TBL] [Abstract][Full Text] [Related]
9. Mice lacking NMDA receptors in parvalbumin neurons display normal depression-related behavior and response to antidepressant action of NMDAR antagonists.
Pozzi L; Pollak Dorocic I; Wang X; Carlén M; Meletis K
PLoS One; 2014; 9(1):e83879. PubMed ID: 24454710
[TBL] [Abstract][Full Text] [Related]
10. Probing NMDA receptor GluN2A and GluN2B subunit expression and distribution in cortical neurons.
Balsara RD; Ferreira AN; Donahue DL; Castellino FJ; Sheets PL
Neuropharmacology; 2014 Apr; 79():542-9. PubMed ID: 24440368
[TBL] [Abstract][Full Text] [Related]
11. Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms.
Kato T; Duman RS
Pharmacol Biochem Behav; 2020 Jan; 188():172827. PubMed ID: 31733218
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effects.
Li SX; Han Y; Xu LZ; Yuan K; Zhang RX; Sun CY; Xu DF; Yuan M; Deng JH; Meng SQ; Gao XJ; Wen Q; Liu LJ; Zhu WL; Xue YX; Zhao M; Shi J; Lu L
Mol Psychiatry; 2018 Mar; 23(3):597-608. PubMed ID: 28439098
[TBL] [Abstract][Full Text] [Related]
13. Ketamine activated glutamatergic neurotransmission by GABAergic disinhibition in the medial prefrontal cortex.
Zhang B; Yang X; Ye L; Liu R; Ye B; Du W; Shen F; Li Q; Guo F; Liu J; Guo F; Li Y; Xu Z; Liu Z
Neuropharmacology; 2021 Aug; 194():108382. PubMed ID: 33144117
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.
Gideons ES; Kavalali ET; Monteggia LM
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8649-54. PubMed ID: 24912158
[TBL] [Abstract][Full Text] [Related]
15. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
Miller OH; Moran JT; Hall BJ
Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
[TBL] [Abstract][Full Text] [Related]
16. Ketamine Administration During the Second Postnatal Week Alters Synaptic Properties of Fast-Spiking Interneurons in the Medial Prefrontal Cortex of Adult Mice.
Jeevakumar V; Kroener S
Cereb Cortex; 2016 Mar; 26(3):1117-29. PubMed ID: 25477370
[TBL] [Abstract][Full Text] [Related]
17. GluN2A mediates ketamine-induced rapid antidepressant-like responses.
Su T; Lu Y; Fu C; Geng Y; Chen Y
Nat Neurosci; 2023 Oct; 26(10):1751-1761. PubMed ID: 37709995
[TBL] [Abstract][Full Text] [Related]
18. Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects.
Hare BD; Shinohara R; Liu RJ; Pothula S; DiLeone RJ; Duman RS
Nat Commun; 2019 Jan; 10(1):223. PubMed ID: 30644390
[TBL] [Abstract][Full Text] [Related]
19. GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine.
Miller OH; Yang L; Wang CC; Hargroder EA; Zhang Y; Delpire E; Hall BJ
Elife; 2014 Oct; 3():e03581. PubMed ID: 25340958
[TBL] [Abstract][Full Text] [Related]
20. Cortical and raphe GABA
Pham TH; Defaix C; Nguyen TML; Mendez-David I; Tritschler L; David DJ; Gardier AM
Pharmacol Biochem Behav; 2020 May; 192():172913. PubMed ID: 32201299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
